RM
RMD
Latest · Mar 31, 2026
Quarter ended Mar 31, 2026 · FY2026 Q3

ResMed Inc. stock research

ResMed (RMD) Free Cash Flow — Quarter Ended Mar 31, 2026

Operating cash flow improved sharply from the prior quarter, lifting free cash flow and margin despite revenue being stable. Compared to the same quarter last year, operating cash flow and free cash flow were lower while revenue was higher.

Free cash flow takeaway

A quick read on the company's cash generation and what it means for investors.

Operating cash flow improved sharply from the prior quarter, lifting free cash flow and margin despite revenue being stable. Compared to the same quarter last year, operating cash flow and free cash flow were lower while revenue was higher.

  • Revenue was unchanged from the prior quarter, but operating cash flow rose significantly, resulting in a higher free cash flow and margin. Capital expenditure was slightly higher than both the prior quarter and the year-ago quarter.
  • Compared to the prior quarter, free cash flow and margin were substantially higher, driven by stronger operating cash flow. Versus the same quarter last year, free cash flow and margin were lower, as operating cash flow declined while revenue increased.

FCF snapshot

Quarterly and TTM cash-flow metrics with the minimum valuation context.

TTM free cash flow

$1.8B

Trailing twelve-month free cash flow.

Quarter free cash flow

$520.5M

Free cash flow in the selected fiscal quarter.

Operating cash flow

$554.1M

Cash generated by operations before capital spending.

CapEx

$33.7M

Capital spending and related asset purchases.

FCF margin

36.4%

The share of revenue converted into free cash flow.

TTM FCF yield

6.1%

TTM FCF divided by market capitalization.

Cash flow trend

A short quarterly history shows whether FCF is scaling with revenue or only spiking for one period.

PeriodRevenueOperating CFCapExFCFFCF margin
2025-06-30$1.3B$538.8M$30.6M$508.2M37.7%
2025-09-30$1.3B$457.3M$43.0M$414.4M31.0%
2025-12-31$1.4B$339.7M$28.5M$311.2M21.9%
2026-03-31$1.4B$554.1M$33.7M$520.5M36.4%

Cash conversion quality

Checks that separate high-quality free cash flow from accounting noise or working-capital timing.

FCF / net income130.5%Shows whether accounting earnings convert into cash.
CapEx / revenue2.4%Lower capital intensity usually supports FCF margin.
Net cash$1.3BCash and equivalents minus total debt.

Recent events shaping cash flow

Near-term business events that help explain the free cash flow result.

Supportive

Operating Cash Flow Recovery

Operating cash flow increased substantially from the prior quarter, which was the primary factor behind the improvement in free cash flow and margin. This occurred even though revenue was unchanged.

The stronger operating cash flow directly lifted free cash flow and margin to levels well above the prior quarter.

What the cash flow says

How to interpret the company's free cash flow beyond the headline number.

Revenue was unchanged from the prior quarter, but operating cash flow rose significantly, resulting in a higher free cash flow and margin. Capital expenditure was slightly higher than both the prior quarter and the year-ago quarter.

Compared to the prior quarter, free cash flow and margin were substantially higher, driven by stronger operating cash flow. Versus the same quarter last year, free cash flow and margin were lower, as operating cash flow declined while revenue increased.

Monitor whether operating cash flow can sustain its current level given the decline from the year-ago quarter.

Valuation context

A cash-flow page should show how much investors are paying for the cash stream, without turning into a full DCF.

Market capitalization$28.8BUsed as the denominator for FCF yield.
TTM FCF yield6.1%TTM free cash flow divided by market capitalization.
EV / TTM FCF15.7xA quick valuation bridge, not a full DCF.

Peer context

Free cash flow quality is easier to read against related public companies.

RM
RMD

ResMed Inc.

FCF margin

36.4%

FCF yield

6.1%